These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21276229)

  • 1. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model.
    Partecke IL; Kaeding A; Sendler M; Albers N; Kühn JP; Speerforck S; Roese S; Seubert F; Diedrich S; Kuehn S; Weiss UF; Mayerle J; Lerch MM; Hadlich S; Hosten N; Heidecke CD; Puls R; von Bernstorff W
    BMC Cancer; 2011 Jan; 11():40. PubMed ID: 21276229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.
    Yin T; Liu Y; Peeters R; Feng Y; Yu J; Himmelreich U; Oyen R; Ni Y
    Br J Cancer; 2017 Nov; 117(10):1529-1536. PubMed ID: 28910821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
    Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
    Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.
    Partecke LI; Sendler M; Kaeding A; Weiss FU; Mayerle J; Dummer A; Nguyen TD; Albers N; Speerforck S; Lerch MM; Heidecke CD; von Bernstorff W; Stier A
    Eur Surg Res; 2011; 47(2):98-107. PubMed ID: 21720167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer.
    Grimm J; Potthast A; Wunder A; Moore A
    Int J Cancer; 2003 Sep; 106(5):806-11. PubMed ID: 12866043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancer.
    Kruse J; von Bernstorff W; Evert K; Albers N; Hadlich S; Hagemann S; Günther C; van Rooijen N; Heidecke CD; Partecke LI
    Int J Colorectal Dis; 2013 Oct; 28(10):1337-49. PubMed ID: 23657400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume measurement variability in three-dimensional high-frequency ultrasound images of murine liver metastases.
    Wirtzfeld LA; Graham KC; Groom AC; Macdonald IC; Chambers AF; Fenster A; Lacefield JC
    Phys Med Biol; 2006 May; 51(10):2367-81. PubMed ID: 16675858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
    Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
    Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
    Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L
    Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
    Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
    Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
    Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
    Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.